200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 207220-71-1

207220-71-1

207220-71-1 | Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-

CAS No: 207220-71-1 Catalog No: AG002IWE MDL No:

Product Description

Catalog Number:
AG002IWE
Chemical Name:
Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-
CAS Number:
207220-71-1
Molecular Formula:
C22H29OP
Molecular Weight:
340.4388
IUPAC Name:
[(5-methyl-2-propan-2-ylcyclohexyl)-phenylphosphoryl]benzene
InChI:
InChI=1S/C22H29OP/c1-17(2)21-15-14-18(3)16-22(21)24(23,19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3
InChI Key:
BPCNGVCAHAIZEE-UHFFFAOYSA-N
SMILES:
CC1CCC(C(C1)P(=O)(c1ccccc1)c1ccccc1)C(C)C

Properties

Complexity:
409  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
340.196g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
340.447g/mol
Monoisotopic Mass:
340.196g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
17.1A^2
Undefined Atom Stereocenter Count:
3  
Undefined Bond Stereocenter Count:
0
XLogP3:
6  

Literature

Title Journal
Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries. American journal of physiology. Cell physiology 20110701
Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs. Cardiovascular research 20110301
Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1. Journal of molecular and cellular cardiology 20100601
Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents. Journal of molecular and cellular cardiology 20100201
Effects of potassium channel blockers on changes in refractoriness of atrial cardiomyocytes induced by stretch. Experimental biology and medicine (Maywood, N.J.) 20090701
High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5. Biochemical pharmacology 20090115
In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate. The Journal of pharmacology and experimental therapeutics 20060201
In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide. The Journal of pharmacology and experimental therapeutics 20051201

© 2019 Angene International Limited. All rights Reserved.